Stock listing
Stuttgart:N790 LIR Life Sciences Corp. Aktie
German listing (Stuttgart) of LIR Life Sciences Corp. · home listing CSE:SKNY
Follow LIR Life Sciences Corp. into a list and get an email when it puts out news.
Home listing price · CSE:SKNY
$0.135 CAD -0.005 (-3.6%)
Close on Oct 29, 2026 · This listing has no price on 6ix; the price shown is the home listing's, CSE:SKNY · Data provided by Twelve Data
- Day range
- $0.130 – $0.135 CADOct 29, 2026
- Volume
- 20,025 sharesOct 29, 2026
- Traded on an average day
- $3,342 CADMedian day 3,083 shares · 16 days with no trades · last 3 months, Jul 29, 2026 – Oct 29, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| CSE:SKNY · Home | $0.135 CAD | -0.005 (-3.6%) | 20,025 | $0.130 | $0.135 | $0.130 | $0.140 | Close on Oct 29, 2026 |
| Frankfurt:N790 | €0.077 EUR | +0.007 (+9.2%) | — | €0.080 | €0.080 | €0.077 | €0.071 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 29, 2026 – Oct 29, 2026 · CSE:SKNY · CAD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.135 | -0.005 | -3.6% | $0.130 | $0.135 | $0.130 | 20,025 | |
| $0.140 | +0.030 | +27.3% | $0.130 | $0.140 | $0.130 | 13,500 | |
| $0.110 | -0.020 | -15.4% | $0.120 | $0.120 | $0.110 | 78,633 | |
| $0.130 | 0.000 | 0.0% | $0.130 | $0.130 | $0.130 | 0 | |
| $0.130 | 0.000 | 0.0% | $0.130 | $0.130 | $0.130 | 41,075 | |
| $0.130 | -0.020 | -13.3% | $0.140 | $0.140 | $0.130 | 17,300 | |
| $0.150 | -0.020 | -11.8% | $0.160 | $0.160 | $0.150 | 22,426 | |
| $0.170 | -0.020 | -10.5% | $0.170 | $0.170 | $0.170 | 1,652 | |
| $0.190 | -0.010 | -5.0% | $0.190 | $0.190 | $0.190 | 1,578 | |
| $0.200 | 0.000 | 0.0% | $0.200 | $0.200 | $0.200 | 0 | |
| $0.200 | 0.000 | 0.0% | $0.200 | $0.200 | $0.200 | 0 | |
| $0.200 | 0.000 | 0.0% | $0.200 | $0.200 | $0.200 | 0 | |
| $0.200 | -0.020 | -9.1% | $0.200 | $0.200 | $0.200 | 645 | |
| $0.220 | 0.000 | 0.0% | $0.220 | $0.220 | $0.220 | 0 | |
| $0.220 | 0.000 | 0.0% | $0.220 | $0.220 | $0.220 | 0 | |
| $0.220 | 0.000 | 0.0% | $0.220 | $0.220 | $0.220 | 0 | |
| $0.220 | -0.020 | -8.3% | $0.230 | $0.230 | $0.220 | 3,233 | |
| $0.240 | 0.000 | 0.0% | $0.240 | $0.240 | $0.240 | 500 | |
| $0.240 | 0.000 | 0.0% | $0.240 | $0.240 | $0.240 | 0 | |
| $0.240 | 0.000 | 0.0% | $0.240 | $0.240 | $0.240 | 0 | |
| $0.240 | 0.000 | 0.0% | $0.240 | $0.240 | $0.240 | 0 | |
| $0.240 | +0.025 | +11.6% | $0.220 | $0.255 | $0.220 | 50,350 | |
| $0.215 | +0.080 | +59.3% | $0.150 | $0.215 | $0.150 | 13,500 | |
| $0.135 | 0.000 | 0.0% | $0.135 | $0.135 | $0.135 | 0 | |
| $0.135 | 0.000 | 0.0% | $0.140 | $0.140 | $0.135 | 10,100 | |
| $0.135 | -0.025 | -15.6% | $0.160 | $0.160 | $0.135 | 48,618 | |
| $0.160 | -0.010 | -5.9% | $0.160 | $0.160 | $0.160 | 1,000 | |
| $0.170 | -0.010 | -5.6% | $0.180 | $0.180 | $0.170 | 2,500 | |
| $0.180 | -0.020 | -10.0% | $0.200 | $0.200 | $0.165 | 19,437 | |
| $0.200 | -0.080 | -28.6% | $0.270 | $0.270 | $0.195 | 151,570 | |
| $0.280 | +0.010 | +3.7% | $0.280 | $0.280 | $0.280 | 6,500 | |
| $0.270 | -0.030 | -10.0% | $0.275 | $0.275 | $0.270 | 17,000 | |
| $0.300 | 0.000 | 0.0% | $0.290 | $0.300 | $0.290 | 2,000 | |
| $0.300 | 0.000 | 0.0% | $0.300 | $0.300 | $0.300 | 0 | |
| $0.300 | 0.000 | 0.0% | $0.310 | $0.310 | $0.300 | 2,933 | |
| $0.300 | 0.000 | 0.0% | $0.330 | $0.340 | $0.300 | 9,075 | |
| $0.300 | +0.020 | +7.1% | $0.300 | $0.340 | $0.290 | 124,360 | |
| $0.280 | +0.030 | +12.0% | $0.250 | $0.280 | $0.250 | 21,568 | |
| $0.250 | +0.060 | +31.6% | $0.200 | $0.250 | $0.200 | 18,500 | |
| $0.190 | +0.050 | +35.7% | $0.160 | $0.200 | $0.160 | 32,437 | |
| $0.140 | 0.000 | 0.0% | $0.140 | $0.140 | $0.140 | 0 | |
| $0.140 | -0.025 | -15.2% | $0.160 | $0.160 | $0.140 | 15,000 | |
| $0.165 | +0.005 | +3.1% | $0.160 | $0.165 | $0.160 | 2,000 | |
| $0.160 | 0.000 | 0.0% | $0.160 | $0.160 | $0.160 | 500 | |
| $0.160 | 0.000 | 0.0% | $0.160 | $0.160 | $0.160 | 0 | |
| $0.160 | +0.010 | +6.7% | $0.160 | $0.160 | $0.160 | 3,541 | |
| $0.150 | 0.000 | 0.0% | $0.160 | $0.170 | $0.150 | 21,688 | |
| $0.150 | -0.010 | -6.2% | $0.160 | $0.160 | $0.150 | 10,242 | |
| $0.160 | -0.010 | -5.9% | $0.160 | $0.160 | $0.160 | 4,500 | |
| $0.170 | 0.000 | 0.0% | $0.170 | $0.170 | $0.170 | 0 | |
| $0.170 | -0.010 | -5.6% | $0.170 | $0.180 | $0.160 | 31,750 | |
| $0.180 | 0.000 | 0.0% | $0.180 | $0.180 | $0.180 | 0 | |
| $0.180 | +0.015 | +9.1% | $0.140 | $0.180 | $0.140 | 45,395 | |
| $0.165 | -0.005 | -2.9% | $0.165 | $0.165 | $0.165 | 2,668 | |
| $0.170 | -0.030 | -15.0% | $0.170 | $0.170 | $0.105 | 141,650 | |
| $0.200 | 0.000 | 0.0% | $0.200 | $0.230 | $0.100 | 71,650 | |
| $0.200 | -0.050 | -20.0% | $0.240 | $0.240 | $0.200 | 3,572 | |
| $0.250 | -0.010 | -3.8% | $0.250 | $0.290 | $0.250 | 6,000 | |
| $0.260 | -0.010 | -3.7% | $0.260 | $0.260 | $0.260 | 1,100 | |
| $0.270 | -0.030 | -10.0% | $0.270 | $0.270 | $0.270 | 1,000 | |
| $0.300 | -0.030 | -9.1% | $0.300 | $0.300 | $0.300 | 3,620 | |
| $0.330 | -0.010 | -2.9% | $0.330 | $0.330 | $0.330 | 2,000 | |
| $0.340 | -0.030 | -8.1% | $0.340 | $0.340 | $0.340 | 500 | |
| $0.370 | -0.050 | -11.9% | $0.370 | $0.370 | $0.370 | 1,000 |
- Ticker
- Stuttgart:N790
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Stuttgart
- Currency
- EUR
What changed lately
Latest news
LIR Life Sciences Signs Development Services Agreement with Oxygen Handel GmbH (OH) to Advance Regulatory and Preclinical Roadmap for Transdermal Obesity Pipeline
Jul 16, 2026
Closed $0.40 (0.0%) on Jul 17, 2026
LIR Life Sciences Completes Comparative Animal Study Showing Successful Protamine-Enhanced Permeation Transport of Both Semaglutide and Tirzepatide
Jun 17, 2026
Closed $0.35 (-7.9%) on Jun 18, 2026
LIR Life Sciences Announces Initiation of Phase 1 Macromolecule-Enabled Transdermal Delivery Development with Neuland Laboratories
May 22, 2026
Closed $0.55 (+1.9%) on May 25, 2026
LIR Life Sciences Launches Ex Vivo Animal Study to Evaluate Protamine Enhanced Transdermal Transport of Larger Format Therapeutic Molecules
Apr 28, 2026
Closed $0.55 (+14.6%) on Apr 29, 2026
LIR Life Sciences Corp. Announces Agreement with Resilience BioSciences Inc.
Apr 20, 2026
Closed $0.50 (+1.0%) on Apr 21, 2026
LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Jan 29, 2026
Closed $2.03 (+2.5%) on Jan 30, 2026
LIR Life Sciences Completes Design of Ex Vivo Animal Study to Evaluate Novel Transdermal Agents for Transport of Larger Therapeutic Molecules
Jan 22, 2026
Closed $2.00 (+8.1%) on Jan 23, 2026
LIR Life Sciences Launches Comparative Animal Study to Advance Transdermal Delivery of Second Generation GLP/GIP-based Obesity Therapies
Jan 15, 2026
Closed $1.95 (+1.0%) on Jan 16, 2026
LIR Life Engages Neuland Labs to Advance Development of Cell Penetrating Peptides for Transdermal GLP-1/GIP Platform
Jan 8, 2026
Closed $2.27 (+0.4%) on Jan 9, 2026
LIR Life Sciences Announces Appointment of Dr. Peter Singer as Scientific Advisor
Dec 18, 2025
Closed $1.32 (+0.8%) on Dec 19, 2025
LIR Life Sciences Corp. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 14 in the last 12 months · 14 in all · newest Jul 16, 2026 · oldest 2025
Where LIR Life Sciences Corp. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| CSE:SKNY · Home listing | CSE | Canada | CAD |
| gettex:N790 | gettex | Germany | EUR |
| LS Exchange:A41QA9 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A41QA9 | Lang & Schwarz | Germany | EUR |
| OTC:BBCMF | OTC | United States | USD |
| Tradegate:N790 | Tradegate | Germany | EUR |
| Cboe Canada:SKNY | Cboe Canada | Canada | CAD |
| Munich:N790 | Munich | Germany | EUR |
| Frankfurt:N790 | Frankfurt | Germany | EUR |
| Hamburg:N790 | Hamburg | Germany | EUR |
| Stuttgart:N790 · This page | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about LIR Life Sciences Corp.